RecruitingPhase 3NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Sponsor: Eli Lilly and Company
Boston, MA · Waltham, MA · +9 more sites
2 recruiting crohn's disease studies with a site in Waltham, MA.
Sponsor: Eli Lilly and Company
Boston, MA · Waltham, MA · +9 more sites
Sponsor: AbbVie
Waltham, MA · +10 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.